Accetto Utilizziamo cookies per migliorare il nostro servizio e realizzare statistiche. Questa funzione puó essere disattivata cambiando la configurazione del browser. Continuando a navigare senza modificare questi parametri, consideriamo che l’uso di cookies sia accettato
Stock No. | Dimensioni | Prezzo ($) | Quantità | Disponibilità |
---|---|---|---|---|
J60378-#0 | 5mg | 128,00 |
|
|
J60378-MA | 10mg | 200,00 |
|
|
J60378-MB | 25mg | 351,00 |
|
|
A potent, highly selective and reversible inhibitor of the 20S proteasome, Bortezomib is used as an antineoplastic agent, which controls the growth of cancer cells. It is also useful in the treatment of multiple myeloma.
Roelofs, J. Proteasome inhibition by bortezomib: A left hook and a right punch. EBioMedicine 2015, 2 (7), 619-620.
Pantani, L.; Zamagni, E.; Zannetti, B. A.; Pezzi, A.; Tacchetti, P.; Brioli, A.; Mancuso, K.; Perrone, G.; Rocchi, S.; Tosi, P.; Cavo, M. Bortezomib and dexamethasone as salvage therapy in patients with relapsed/refractory multiple myeloma: analysis of long-term clinical outcomes. Ann. Hematol. 2014, 93 (1), 123-128.
Dichiarazioni di rischio (UE): H300-H310-H330-H372
Fatal if swallowed. Fatal in contact with skin. Fatal if inhaled. Causes damage to organs through prolonged or repeated exposure.
Dichiarazioni precauzionali: P301+P310a-P304+P340-P320-P330-P405-P501a
IF SWALLOWED: Immediately call a POISON CENTER/doctor IF INHALED: Remove to fresh air and keep at rest in a position comfortable for breathing. Specific treatment is urgent (see label). Rinse mouth. Store locked up. Dispose of contents/container in accordance with local/regional/national/international regulations.